Southwest Houston Research

Houston, Texas 77099

1 studies enrolling now · 4 studies all time

What they study most

Alport Syndrome, Autosomal Dominant Polycystic Kidney, Chronic Kidney Disease, Chronic Kidney Diseases, End Stage Kidney Disease

Studies at this site

• Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD) — Recruiting now
• A Phase 2/3 Trial of the Efficacy and Safety of Bardoxolone Methyl in Patients With Alport Syndrome - CARDINAL — Completed
• An Extended Access Program for Bardoxolone Methyl in Patients With CKD (EAGLE) — Stopped early
• Study of Phosphate Levels in Patients With Chronic Kidney Disease — Completed